BOB体育

A Veteran鈥檚 Resilience: An Unwavering Journey to Health

He served his country for almost two decades. Then, doctors from BOB体育 were able to return the favor. Dick鈥檚 military journey began in 1979 when he鈥�

Studies: Inflammation-targeting antibody boosts preterm birth outcomes, prevents obesity-linked liver disease

June 23, 2023

JUPITER, Fla. 鈥� Targeting a master-regulator of inflammation with a monoclonal antibody potentially improves two unrelated conditions with limited treatment鈥�

BOB体育 screening patients in what might be largest fatty liver study of its kind in the U.S.

December 21, 2020

It鈥檚 a potential killer. And many of the people who are most susceptible to the disease don鈥檛 even know it exists. Physicians remain uncertain of its鈥�

BOB体育 researcher helps show hormone can reverse inflammation from fatty liver disease

November 20, 2020

Pushed by the obesity epidemic, a rising number of Americans are being diagnosed with nonalcoholic fatty liver disease, a condition that can lead to liver鈥�

Landmark multiorgan surgery at BOB体育 Shands reverses patient鈥檚 terminal prognosis

September 1, 2020

Allen Korson went from a kidney stone ailment to needing a multiorgan transplant, both lungs and a liver, one of the rarest procedures performed in the United鈥�

Study helps hepatitis C patients, shows path for accelerating research and potential for drug approvals

November 25, 2019

Read the journal article here, which also contains a list of co-authors鈥� disclosures of funding and possible conflicts:鈥�

Weight Loss with Canaglifozin Linked to Improvement in Nonalcoholic Fatty Liver Disease

Clinicians frequently overlook nonalcoholic fatty liver disease in their patients who have Type 2 diabetes. Yet it is estimated that approximately 70% of obese鈥�

UF researchers find link between demographics and liver cancer

March 11, 2019

A new study by University of Florida Health researchers finds that Hispanics, as well as the elderly and people with diabetes, have a higher risk of developing鈥�

2018 in Review: Reflecting on Our Achievements, Part 2

March 5, 2019

Part 2 of our 鈥�2018 Year in Review鈥� focuses on the research institutes and centers that are part of the BOB体育 family: Cancer Center Clinical and鈥�

New hepatitis C therapy effective, costs less for patients and payers, UF researchers find

February 21, 2019

Additional Video Available here: https://www.youtube.com/watch?v=vqkyhha_AX8 Patients who take new oral direct-acting antivirals for hepatitis C have lower鈥�